These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30730250)

  • 1. Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
    Chang CH; Lane HY; Tseng PT; Chen SJ; Liu CY; Lin CH
    J Psychopharmacol; 2019 Apr; 33(4):436-448. PubMed ID: 30730250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N-methyl-D-aspartate receptor enhancing agents on cognition in dementia: an exploratory systematic review and meta-analysis of randomized controlled trials.
    Chang CH; Liu CY; Chen SJ; Tsai HC
    Sci Rep; 2021 Nov; 11(1):22996. PubMed ID: 34836972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials.
    Chang CH; Lin CH; Liu CY; Chen SJ; Lane HY
    J Psychopharmacol; 2020 May; 34(5):495-505. PubMed ID: 32122256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia.
    Singh SP; Singh V
    CNS Drugs; 2011 Oct; 25(10):859-85. PubMed ID: 21936588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Iwata N
    J Psychiatr Res; 2013 Sep; 47(9):1143-9. PubMed ID: 23692933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.
    Iwata Y; Nakajima S; Suzuki T; Keefe RS; Plitman E; Chung JK; Caravaggio F; Mimura M; Graff-Guerrero A; Uchida H
    Mol Psychiatry; 2015 Oct; 20(10):1151-60. PubMed ID: 26077694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor.
    Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE
    JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
    Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis.
    Tsai GE; Lin PY
    Curr Pharm Des; 2010; 16(5):522-37. PubMed ID: 19909229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of
    Goh KK; Wu TH; Chen CH; Lu ML
    J Psychopharmacol; 2021 Mar; 35(3):236-252. PubMed ID: 33406959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic drugs for schizophrenia.
    Tuominen HJ; Tiihonen J; Wahlbeck K
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003730. PubMed ID: 16625590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial.
    Lin CY; Liang SY; Chang YC; Ting SY; Kao CL; Wu YH; Tsai GE; Lane HY
    World J Biol Psychiatry; 2017 Aug; 18(5):357-368. PubMed ID: 26691576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophrenia.
    Weiser M; Heresco-Levy U; Davidson M; Javitt DC; Werbeloff N; Gershon AA; Abramovich Y; Amital D; Doron A; Konas S; Levkovitz Y; Liba D; Teitelbaum A; Mashiach M; Zimmerman Y
    J Clin Psychiatry; 2012 Jun; 73(6):e728-34. PubMed ID: 22795211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive improvement of acetylcholinesterase inhibitors in schizophrenia.
    Santos B; González-Fraile E; Zabala A; Guillén V; Rueda JR; Ballesteros J
    J Psychopharmacol; 2018 Nov; 32(11):1155-1166. PubMed ID: 30324844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine.
    Forsyth JK; Bachman P; Mathalon DH; Roach BJ; Ye E; Asarnow RF
    Schizophr Bull; 2017 Sep; 43(5):1123-1133. PubMed ID: 28338977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Dementia Drugs for Psychopathology and Cognitive Impairment in Schizophrenia: A Systematic Review and Meta-Analysis.
    Kishi T; Ikuta T; Oya K; Matsunaga S; Matsuda Y; Iwata N
    Int J Neuropsychopharmacol; 2018 Aug; 21(8):748-757. PubMed ID: 29762677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of adjunctive D-Cycloserine for the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Kuppili PP; Menon V; Sathyanarayanan G; Sarkar S; Andrade C
    J Neural Transm (Vienna); 2021 Feb; 128(2):253-262. PubMed ID: 33439362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials.
    Zheng W; Zhu XM; Zhang QE; Cai DB; Yang XH; Zhou YL; Ungvari GS; Ng CH; He SH; Peng XJ; Ning YP; Xiang YT
    Schizophr Res; 2019 Jul; 209():12-21. PubMed ID: 31164254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rosenblat JD; Kakar R; McIntyre RS
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.